Skip to main content

Aerovate Therapeutics shares skyrocket in first day of trading

Aerovate Therapeutics, a biotech startup focused on rare cardiopulmonary disease, has nailed its Nasdaq landing, with shares jumping in the first day of trading.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.